SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001590750-21-000023
Filing Date
2021-03-25
Accepted
2021-03-25 16:06:56
Documents
17
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vrdn-20210325.htm   iXBRL 8-K 38900
2 EX-99.1 fy2020ex991.htm EX-99.1 85045
8 viridian_logoxcolorx170j1a.jpg GRAPHIC 7056
9 vrdn-20210325_g1.jpg GRAPHIC 7056
  Complete submission text file 0001590750-21-000023.txt   308045

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrdn-20210325.xsd EX-101.SCH 2444
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrdn-20210325_cal.xml EX-101.CAL 724
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrdn-20210325_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrdn-20210325_lab.xml EX-101.LAB 24977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrdn-20210325_pre.xml EX-101.PRE 13201
10 EXTRACTED XBRL INSTANCE DOCUMENT vrdn-20210325_htm.xml XML 11059
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 21772416
SIC: 8071 Services-Medical Laboratories